FEATURE ARTICLES
The market for GLP-1 agonists is booming and expected to only get bigger. As rates for obesity and cardiovascular disease increase, so too does the demand for GLP-1 drugs.
- From Lab to Plant: Managing Operational Environment During Scale-Up
- Sanofi's Digitalization Road Trip Shifts Into High Gear
- Why Pharmaceutical And Medical Device Risks Must Be Analyzed By Their Risk Mechanisms
- The Regulatory Imperative To Improve Environmental And Sustainability Stewardship In Biopharma
- Operating And Maintaining Pharmaceutical Gas Distribution Systems
- August 2025 — CDMO Opportunities And Threats Report
- The New FDA Era Of Radical Transparency And Pervasive Oversight
PHARMA ONLINE WHITE PAPERS
-
7 Tips To Improve OT Cybersecurity For Life Sciences
Leverage the insights of cybersecurity specialists and industry experts to gain a broader context for more informed decision-making regarding actions and next steps to improve OT cybersecurity.
-
A Scalable Single-Use Two-Step pDNA Purification Process3/6/2024
Evaluate the performance of a single-use two-step plasmid purification process, and see how it compares to the existing three-step purification method.
-
The Role Of The Technical Transfer Executive Sponsor10/30/2023
Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.
-
Enabling Quality By Design9/8/2025
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
Isolators For Pharmacy Compounding – Time For Change?3/14/2025
Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.
-
Process Analytical Technology In The ADC Bioconjugation Process4/23/2025
Integrating Process Analytical Technology into validated GMP processes is complex and costly, which requires thorough validation of equipment and cleaning methods. Explore more about PAT's role in ADC production.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Bypassing The Challenges Of Paper-Based Validation
- 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay
- Streamlining Data For Efficient Therapeutic Manufacturing
- Advantages Of Spray-Dried Mannitol In Roll Compaction
- Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development
NEWSLETTER ARCHIVE
- 10.02.25 -- Automation Platforms For Real-Time Compliance, Data Mobility, And Instrument Optimization
- 10.02.25 -- STREAM Edition: Understanding Barrier Systems
- 10.01.25 -- How Can Nanotechnology Transform Drug Delivery?
- 10.01.25 -- Why Process Safety Matters — And What's Next For Pharma Manufacturing
- 09.30.25 -- A New Dimension For An Enhanced Injection Experience
INDUSTRY NEWS
-
Pfizer Strengthens Obesity Foothold With Metsera Acquisition
After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
FDA Cracks Down On GLP-1 Imports
GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
Oregon Court Upholds Drug Price Transparency Law
The law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
-
Spray Drying Market Poised To Nearly Double By 2033
The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs.
-
AbbVie Enters Psychedelic Market With Bretisilocin Acquisition
Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
OPTIMA Machinery Ireland Ltd. Officially Founded10/2/2025
The Optima Group has founded a new company, OPTIMA machinery Ireland Ltd. With this new location, Optima is expanding its international presence and strengthening its activities in Ireland.
-
CDMO AbbVie Begins Construction On Biologics Manufacturing Facility Expansion In Massachusetts10/2/2025
AbbVie today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.
-
Federal Equipment Company Announces Exclusive Sale Of Brand-New Aseptic Processing & Sterilization Equipment10/2/2025
Federal Equipment Company is pleased to announce the exclusive consignment of a suite of brand-new, never-used equipment designed for pharmaceutical and biotech aseptic processing. These state-of-the-art systems from leading manufacturers are now available for immediate purchase, offering buyers a unique opportunity to acquire high-performance technologies without the typical lead times of new builds.
-
Precision Biologics Manufacturing Expands U.S. Production with Nevada Groundbreaking10/1/2025
Precision Biologics Manufacturing, a New Horizon Medical Solutions (NHMS) company, announced a groundbreaking for its manufacturing facility, to develop advanced biologics technology and to bring MedTech jobs to Southern Nevada. Operated by Precision Biologics Manufacturing, the center will expand U.S.-based biologics production and create more than 200 to 300 healthcare-centric jobs in the Las Vegas Valley beginning in the second half of 2026.
-
ROSS Ribbon Blender Optimized For Efficient Powder Handling9/30/2025
Customizable ROSS Ribbon Blenders deliver reliable mixing of food, nutraceuticals, cosmetics, personal care products, in addition to chemicals, plastics, building materials and agricultural products.